Peter Sandys

Peter Sandys

Director/Board Member at
Quanta Dialysis Technologies Ltd.
Finance
Health Technology
Miscellaneous

Profile

Peter Sandys is Chairman of Seroba.
He was a co-founder of the firm, acting as Managing Partner until 2021 when he transitioned to the role of Chairman.
Peter has held many directorships in the fund management, technology and financial services industries.
He was previously Managing Director of ABN Amro Corporate Finance (Ireland) Limited where he had responsibility for the firm’s capital markets and venture capital businesses.
Prior to joining ABN Amro, Peter worked in Corporate Advisory Services for Ernst & Young (E&Y) in London and Dublin.
During this period, Peter was also seconded to 3i venture capital.
Prior to joining E&Y, he worked for KPMG.
Peter has a BBS degree from TCD and is a Chartered Accountant.
He has served twice as Chairman of the Irish Venture Capital Association and was a member of the Irish Stock Exchange’s New Issues Committee and the committee of the Irish Bio Industries Association.
He was also formerly a member of the Securities Institute, a Registered Stockbroker and a member of the Institute of Taxation in Ireland.
Peter sits on the board of Quanta Dialysis Technologies and was previously on the board of PrecisionBiotics (acquired by Novozymes.)

Peter Sandys active positions

CompaniesPositionStart
Director/Board Member -

Former positions of Peter Sandys

CompaniesPositionEnd
Chairman 2023-11-30
Director/Board Member 2016-08-25
Director/Board Member 2012-02-02
Director/Board Member -
Corporate Officer/Principal -
See the detail of Peter Sandys's experience

Training of Peter Sandys

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

37

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Finance

Health Technology

Health Technology

Miscellaneous

Consumer Services

Finance

Commercial Services

Health Technology

ABN AMRO Corporate Finance

Finance

Finance

Ernst & Young LLP (Research Firm)